Latest Breaking News On - சுரப்பி பார்மா லிமிடெட் ஆன் - Page 1 : comparemela.com

Gland Pharma inks deal with RDIF for 252mn doses of Sputnik V vaccine ANI | Updated: Mar 16, 2021 22:34 IST Mumbai (Maharashtra) [India], March 16 (ANI): Gland Pharma Ltd on Tuesday said that it has entered into an agreement with the Russian Direct Investment Fund (RDIF) for the supply of 252 million doses of Sputnik V (Russian made) vaccine against COVID-19. Gland Pharma will be leveraging its manufacturing capabilities for the production of Sputnik V COVID-19 vaccine. The agreement will see Gland Pharma utilising its Drug Substance and Drug Product facilities at its sites in Hyderabad, the statement published by the Bombay Stock Exchange said, as quoted by Sputnik.

Andhra pradeshGland pharma ltd onDr reddy laboratories ltdRussian direct investment fundBombay stock exchangeGland pharma ltdGland pharmaDrug substanceDrug productLaboratories ltdSputnik vCovid vaccineஆந்திரா பிரதேஷ்சுரப்பி பார்மா லிமிடெட் ஆன்டாக்டர் சிவப்பு ஆய்வகங்கள் லிமிடெட்ரஷ்ய நேரடி முதலீடு நிதி